nonsignificant

Related by string. * * nonsignificant trend . statistically nonsignificant . rating nonsignificant . nonsignificant difference *

Related by context. Frequent words. (Click for all words.) 72 statistically significant 68 P = .# 65 reach statistical significance 65 confidence interval CI 65 % CI #.#-#.# [002] 63 % CI #.#-#.# [006] 62 p = 62 p = #.# [002] 61 HbA1c levels 61 LVEF 61 placebo p = 61 myocardial infarction MI 61 statistically significant p 61 nonresponders 61 statistically significant differences 60 statistically significant reduction 60 cardiovascular mortality 60 Secondary endpoints included 60 placebo 60 composite endpoint 60 unfractionated heparin 59 pioglitazone 59 thromboembolic events 59 p = #.# [004] 58 laboratory abnormalities 58 Postoperative 58 severe hypoglycemia 58 multivariate analysis 58 nmol L 58 placebo p 58 microalbuminuria 58 valsartan 58 tiotropium 57 leukopenia 57 thromboembolism 57 glomerular filtration rate 57 febrile neutropenia 57 lamotrigine 57 vertebral fracture 57 albuminuria 57 mmol L 57 CI = 57 Secondary endpoints 57 covariates 57 discontinuations due 56 HbA1c 56 secondary endpoint 56 clinically meaningful 56 treatment emergent adverse 56 glimepiride 56 statistical significance 56 rosuvastatin 56 55 fasting plasma glucose 55 proteinuria 55 n = 55 symptom severity 55 ramipril 55 myocardial ischemia 55 histologic 55 cardiovascular morbidity 55 comorbidity 55 insulin glargine 55 renal insufficiency 55 g dL 55 mg dL 55 mitoxantrone 54 fluoxetine 54 olanzapine 54 discontinuations 54 myocardial infarction 54 left ventricular hypertrophy 54 comorbid 54 lipid profiles 54 adalimumab 54 mg BID 54 Secondary endpoints include 54 mg dose 54 depressive symptoms 54 comorbid conditions 54 inverse association 54 achieve statistical significance 54 rs# [003] 54 etanercept 54 postoperative complications 54 creatinine clearance 54 clopidogrel 54 hsCRP 54 tumor recurrence 54 aripiprazole 54 serum cholesterol 54 renal dysfunction 54 sinus rhythm 53 exacerbations 53 bosentan 53 non inferiority 53 enoxaparin 53 adjuvant chemotherapy 53 sustained virologic response 53 FEV1 53 FOLFOX

Back to home page